Cargando…
Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis
OBJECTIVE: We aimed to systematically identify the possible risk factors responsible for severe cases. METHODS: We searched PubMed, Embase, Web of science and Cochrane Library for epidemiological studies of confirmed COVID-19, which include information about clinical characteristics and severity of...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092779/ https://www.ncbi.nlm.nih.gov/pubmed/33939733 http://dx.doi.org/10.1371/journal.pone.0250602 |
_version_ | 1783687693323993088 |
---|---|
author | Li, Xinyang Zhong, Xianrui Wang, Yongbo Zeng, Xiantao Luo, Ting Liu, Qing |
author_facet | Li, Xinyang Zhong, Xianrui Wang, Yongbo Zeng, Xiantao Luo, Ting Liu, Qing |
author_sort | Li, Xinyang |
collection | PubMed |
description | OBJECTIVE: We aimed to systematically identify the possible risk factors responsible for severe cases. METHODS: We searched PubMed, Embase, Web of science and Cochrane Library for epidemiological studies of confirmed COVID-19, which include information about clinical characteristics and severity of patients’ disease. We analyzed the potential associations between clinical characteristics and severe cases. RESULTS: We identified a total of 41 eligible studies including 21060 patients with COVID-19. Severe cases were potentially associated with advanced age (Standard Mean Difference (SMD) = 1.73, 95% CI: 1.34–2.12), male gender (Odds Ratio (OR) = 1.51, 95% CI:1.33–1.71), obesity (OR = 1.89, 95% CI: 1.44–2.46), history of smoking (OR = 1.40, 95% CI:1.06–1.85), hypertension (OR = 2.42, 95% CI: 2.03–2.88), diabetes (OR = 2.40, 95% CI: 1.98–2.91), coronary heart disease (OR: 2.87, 95% CI: 2.22–3.71), chronic kidney disease (CKD) (OR = 2.97, 95% CI: 1.63–5.41), cerebrovascular disease (OR = 2.47, 95% CI: 1.54–3.97), chronic obstructive pulmonary disease (COPD) (OR = 2.88, 95% CI: 1.89–4.38), malignancy (OR = 2.60, 95% CI: 2.00–3.40), and chronic liver disease (OR = 1.51, 95% CI: 1.06–2.17). Acute respiratory distress syndrome (ARDS) (OR = 39.59, 95% CI: 19.99–78.41), shock (OR = 21.50, 95% CI: 10.49–44.06) and acute kidney injury (AKI) (OR = 8.84, 95% CI: 4.34–18.00) were most likely to prevent recovery. In summary, patients with severe conditions had a higher rate of comorbidities and complications than patients with non-severe conditions. CONCLUSION: Patients who were male, with advanced age, obesity, a history of smoking, hypertension, diabetes, malignancy, coronary heart disease, hypertension, chronic liver disease, COPD, or CKD are more likely to develop severe COVID-19 symptoms. ARDS, shock and AKI were thought to be the main hinderances to recovery. |
format | Online Article Text |
id | pubmed-8092779 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-80927792021-05-07 Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis Li, Xinyang Zhong, Xianrui Wang, Yongbo Zeng, Xiantao Luo, Ting Liu, Qing PLoS One Research Article OBJECTIVE: We aimed to systematically identify the possible risk factors responsible for severe cases. METHODS: We searched PubMed, Embase, Web of science and Cochrane Library for epidemiological studies of confirmed COVID-19, which include information about clinical characteristics and severity of patients’ disease. We analyzed the potential associations between clinical characteristics and severe cases. RESULTS: We identified a total of 41 eligible studies including 21060 patients with COVID-19. Severe cases were potentially associated with advanced age (Standard Mean Difference (SMD) = 1.73, 95% CI: 1.34–2.12), male gender (Odds Ratio (OR) = 1.51, 95% CI:1.33–1.71), obesity (OR = 1.89, 95% CI: 1.44–2.46), history of smoking (OR = 1.40, 95% CI:1.06–1.85), hypertension (OR = 2.42, 95% CI: 2.03–2.88), diabetes (OR = 2.40, 95% CI: 1.98–2.91), coronary heart disease (OR: 2.87, 95% CI: 2.22–3.71), chronic kidney disease (CKD) (OR = 2.97, 95% CI: 1.63–5.41), cerebrovascular disease (OR = 2.47, 95% CI: 1.54–3.97), chronic obstructive pulmonary disease (COPD) (OR = 2.88, 95% CI: 1.89–4.38), malignancy (OR = 2.60, 95% CI: 2.00–3.40), and chronic liver disease (OR = 1.51, 95% CI: 1.06–2.17). Acute respiratory distress syndrome (ARDS) (OR = 39.59, 95% CI: 19.99–78.41), shock (OR = 21.50, 95% CI: 10.49–44.06) and acute kidney injury (AKI) (OR = 8.84, 95% CI: 4.34–18.00) were most likely to prevent recovery. In summary, patients with severe conditions had a higher rate of comorbidities and complications than patients with non-severe conditions. CONCLUSION: Patients who were male, with advanced age, obesity, a history of smoking, hypertension, diabetes, malignancy, coronary heart disease, hypertension, chronic liver disease, COPD, or CKD are more likely to develop severe COVID-19 symptoms. ARDS, shock and AKI were thought to be the main hinderances to recovery. Public Library of Science 2021-05-03 /pmc/articles/PMC8092779/ /pubmed/33939733 http://dx.doi.org/10.1371/journal.pone.0250602 Text en © 2021 Li et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Li, Xinyang Zhong, Xianrui Wang, Yongbo Zeng, Xiantao Luo, Ting Liu, Qing Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis |
title | Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis |
title_full | Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis |
title_fullStr | Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis |
title_full_unstemmed | Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis |
title_short | Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis |
title_sort | clinical determinants of the severity of covid-19: a systematic review and meta-analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092779/ https://www.ncbi.nlm.nih.gov/pubmed/33939733 http://dx.doi.org/10.1371/journal.pone.0250602 |
work_keys_str_mv | AT lixinyang clinicaldeterminantsoftheseverityofcovid19asystematicreviewandmetaanalysis AT zhongxianrui clinicaldeterminantsoftheseverityofcovid19asystematicreviewandmetaanalysis AT wangyongbo clinicaldeterminantsoftheseverityofcovid19asystematicreviewandmetaanalysis AT zengxiantao clinicaldeterminantsoftheseverityofcovid19asystematicreviewandmetaanalysis AT luoting clinicaldeterminantsoftheseverityofcovid19asystematicreviewandmetaanalysis AT liuqing clinicaldeterminantsoftheseverityofcovid19asystematicreviewandmetaanalysis |